Search
Login
Register
Menu
BJH
Home
News
Newsroom
Links
CongressUpdate
Guidelines
Specials
Hematotrials
Patients
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: Management of non-small cell lung cancer patients EGFR mutated and ALK translocated
“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart.
View cart
Article: Management of non-small cell lung cancer patients EGFR mutated and ALK translocated
€
2.42
Article: Management of non-small cell lung cancer patients EGFR mutated and ALK translocated quantity
Add to cart
SKU:
product-article-10980
Category:
General
Description
Description
Management of non-small cell lung cancer patients EGFR mutated and ALK translocated
Related products
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€
2.42
Add to cart
Article: Highlights in gynaecological cancers
€
2.42
Add to cart
Article: Highlights in digestive oncology
€
2.42
Add to cart
Article: Calendar of events
€
2.42
Add to cart